Vertex Pharmaceuticals
VRTX
#131
Rank
C$178.46 B
Marketcap
$693.00
Share price
0.94%
Change (1 day)
32.51%
Change (1 year)

Earnings for Vertex Pharmaceuticals (VRTX)

Earnings in 2024 (TTM): C$0.26 Billion

According to Vertex Pharmaceuticals's latest financial reports the company's current earnings are C$10.33 Billion. In 2023 the company made an earning of C$6.19 Billion, an increase over its 2022 earnings that were of C$6.00 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Vertex Pharmaceuticals from 1990 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) C$0.26 B-95.65%
2023 C$6.19 B3.19%
2022 C$6.00 B53.56%
2021 C$3.91 B-12.06%
2020 C$4.44 B118.45%
2019 C$2.03 B120.64%
2018 C$0.92 B1473.64%
2017 C$58.65 M197.6%
2016 C$19.7 M-102.97%
2015 -C$0.67 Billion-28.46%
2014 -C$0.93 Billion-51.5%
2013 -C$1.92 Billion-30584.68%
2012 C$6.27 M-95.47%
2011 C$0.13 B
2009 -C$0.84 Billion
2007 -C$0.58 Billion83.1%
2006 -C$0.32 Billion59.02%
2005 -C$0.2 Billion3.28%
2004 -C$0.2 Billion-38.16%
2003 -C$0.32 Billion
2000 -C$53.31 Million-20.38%
1999 -C$66.95 Million31.62%
1998 -C$50.86 Million91.05%
1997 -C$26.63 Million-36.24%
1996 -C$41.76 Million12.45%
1995 -C$37.13 Million27.4%
1994 -C$29.15 Million-1833.33%
1993 C$1.68 M-112.12%
1992 -C$13.88 Million175%
1991 -C$5.05 Million-12.2%
1990 -C$5.75 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
C$2.15 B 499.61%๐Ÿ‡บ๐Ÿ‡ธ USA
C$9.90 B 2,654.78%๐Ÿ‡บ๐Ÿ‡ธ USA
C$23.10 B 6,328.85%๐Ÿ‡บ๐Ÿ‡ธ USA
-C$9.64 Billion-2,782.26%๐Ÿ‡บ๐Ÿ‡ธ USA
C$25.77 B 7,071.54%๐Ÿ‡บ๐Ÿ‡ธ USA
-C$0.15 Billion-141.56%๐Ÿ‡บ๐Ÿ‡ธ USA